RAD52 and neoplasm: They also observed an increased antitumor activity in RAD52-/- cells through an enhanced capacity of cytotoxic T lymphocytes and natural killer cells to directly kill tumor cells (Lieberman et al., 2017; Nogueira et al., 2019).